REAUTHORIZATION; REPORTING REQUIREMENTS.

SEC. 2004. REAUTHORIZATION; REPORTING REQUIREMENTS.(a) Performance Reports.—Section 738A(a) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j–1(a)) is amended—(1) by striking “fiscal year 2018” each place it appears and inserting “fiscal year 2023”; (2) by striking “Medical Device User Fee Amendments of 2017” each place it appears and inserting “Medical Device User Fee Amendments of 2022”; (3) in paragraph (1)—(A) in subparagraph (A), by redesignating the second clause (iv) (relating to analysis) as clause (v); and (B) in subparagraph (A)(iv), by striking “fiscal year 2020” and inserting “fiscal year 2023”; and (4) in paragraph (4), by striking “2018 through 2022” and inserting “2023 through 2027”. (b) Reauthorization.—Section 738A(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j–1(b)) is amended—(1) in paragraph (1), by striking “2022” and inserting “2027”; and (2) in paragraph (5), by striking “2022” and inserting “2027”.